GPX Medical AB (publ) publicerar ett investerarbrev för sommaren 2021

I sommarens nummer får ni läsa en sommarhälsning från VD Hanna Sjöström och om försäljningen av det första NEOLA®-systemet till Tyndall National Institute på University College Cork som kommer att användas i en stor studie på nyfödda barn i samarbete med The Irish Centre for Maternal and Child Health Research på Irland.

Läs pressmeddelandet i sin helhet här med bifogat investerarbrev: Pressmeddelande inkl. investerarbrev juni 2021

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012